IRS1 and type 2 diabetes mellitus: MiR-144 targets IRS1 (insulin receptor substrate-1), a gene highly involved in insulin signaling pathway, and upregulation of this miRNA exhibits a linear relationship with the glycemic status in T2D patients [22].